On the TRAIL toward death receptor-based cancer therapeutics.

Subjects

Subjects :

Animals
Antibodies, Monoclonal, Humanized
Apoptosis drug effects
Apoptosis physiology
Clinical Trials, Phase I as Topic
Humans
Mice
Neoplasms pathology
Antibodies, Monoclonal pharmacology
Neoplasms drug therapy
Receptors, Death Domain
TNF-Related Apoptosis-Inducing Ligand agonists
TNF-Related Apoptosis-Inducing Ligand pharmacology

Details

Language :

English

ISSN :

1527-7755

Volume :

25

Issue :

11

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

17416849

Full Text :

https://doi.org/10.1200/JCO.2006.09.9804